Viewing nowCombinationOlmetin Tablet 20/10 Milligrams
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 202003951 · Approved 2020.05.28 · Insurance code 671706550
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerosis progression and cardiovascular risk
This medication is used for patients who require simultaneous treatment with both Olmesartan Medoxomil and Rosuvastatin. Olmesartan Medoxomil is primarily used for the treatment of essential hypertension and plays a role in controlling blood pressure. Rosuvastatin helps improve lipid levels in patients with hypercholesterolemia and mixed dyslipidemia, which cannot be managed with diet and exercise alone. Additionally, Rosuvastatin is used as an adjunct therapy in patients with familial hypercholesterolemia and dysbetalipoproteinemia, lowering total cholesterol and LDL cholesterol, thereby slowing the progression of atherosclerosis. Furthermore, it is effective in reducing the risks of stroke, myocardial infarction, and vascular remodelling related to cardiovascular disease in high-risk patients. In summary, this medication is used to simultaneously manage hypertension and hyperlipidemia to reduce the risk of cardiovascular disease.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, olmesartan medoxomil/rosuvastatin. ◆ Olmesartan medoxomil 1. Adults The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect occurs within 2 weeks after starting treatment and reaches its maximum effect at about 8 weeks. If blood pressure is not adequately controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients taking diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. 2. Elderly patients No dose adjustment is necessary when this medicine is administered to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose in patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended. ◆ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL-cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL-cholesterol levels, the treatment goal, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients No dose adjustment is necessary. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering this medicine at 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment Although no increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking olmesartan medoxomil and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience of administration.
Safety and efficacy in children under 18 years of age have not been established.
This medication may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Individuals allergic to this medication or its ingredients should not take it, nor should it be used by women who are potentially pregnant or breastfeeding. This medication is not suitable for patients with certain health conditions such as very poor kidney function, those undergoing dialysis, severe liver disease patients, or those with bile duct obstruction. Patients with muscular disorders or at high risk for muscle-related side effects should refrain from taking this medication or do so under caution. Patients at risk of a sudden drop in blood pressure, especially those with decreased body fluid or salt, should be closely monitored when starting this medication. Patients with kidney issues should have their kidney function and electrolyte levels regularly monitored through blood tests. This medication can enhance the blood pressure-lowering effect when taken with other antihypertensive medications, so caution is warranted. Additionally, this medication may affect liver function, so patients with a history of liver disease or heavy alcohol consumption should undergo periodic liver function tests. Symptoms like muscle pain or weakness should be reported to a doctor immediately, and in severe cases, discontinuation of the medication may be necessary. During the course of treatment, there is a risk of hyperkalemia (elevated potassium levels), so potassium levels should be monitored through blood tests. Caution should be exercised while driving or operating hazardous machinery, as side effects like dizziness may occur. There may be interactions with other medications during treatment, so if you are taking other medications, you must inform your doctor or pharmacist. Pregnant or breastfeeding women should not take this medication, and women who may become pregnant should use appropriate contraception. Safety and efficacy in children under 18 years of age have not been established, thus its use is not recommended. Elderly patients should be careful as the drug concentration in the body may increase. In case of overdose, symptoms such as hypotension and palpitations may occur; immediate consultation with a healthcare institution is necessary. This medication should be kept out of reach of children and should not be transferred to other containers.
Increased ALT, Increased AST, Elevated serum creatinine, Decreased creatinine clearance, Headache, Dizziness, Sensory impairment, Neuropathy, Drowsiness, Gastroesophageal reflux disease, Constipation, Dental caries, Dyspepsia, Gastric ulcer, Gastritis, Gastroenteritis, Musculoskeletal rigidity, Atrial fibrillation, Hypoglycemia, Chest pain, Tooth extraction, Thoracic pain, Peripheral edema, Vertigo, Abdominal pain, Nausea, Palpitations, Hypercholesterolemia, Hyperlipidemia, Hyperuricemia, Arthralgia, Arthritis, Myalgia, Rash, Facial edema, Weakness, Angioedema, Anaphylaxis, Vomiting, Chronic malabsorption syndrome, Intestinal vascular edema, Rhabdomyolysis, Hyperkalemia, Acute renal failure, Hair loss, Pruritus, Urticaria, Autoimmune hepatitis, Dizziness (including positional dizziness), Palpitations, Elevated blood pressure, Lumbago, Increased serum creatinine, Diarrhea, Pruritus, Cough, Epistaxis, Upper respiratory tract infection, Asthma, Hypersensitivity reaction including angioedema, Diabetes, Constipation, Nausea, Abdominal pain, Pancreatitis, Pruritus, Rash, Urticaria, Myalgia, Myopathy, Rhabdomyolysis, Weakness, Polyneuropathy, Amnesia, Peripheral neuropathy, Cough, Dyspnea, Diarrhea, Thrombocytopenia, Jaundice, Hepatitis, Increased transaminases, Stevens-Johnson syndrome, Drug reaction with eosinophilia and systemic symptoms syndrome, Lupus-like syndrome, Muscle rupture, Arthralgia, Immune-mediated necrotizing myopathy, Hematuria, Edema, Depression, Sleep disturbances, Interstitial lung disease, Sexual dysfunction, Gynecomastia, Fatal and non-fatal liver failure, Cognitive impairment, Severe muscle weakness, Ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. This will help safely retain the medication's efficacy.
White or pale yellow round film-coated tablets
30 tablets/box [30 tablets (10 tablets/Alu-Alu) × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.